Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14326 - 14350 of 14623 in total

1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea

Experimental

ES-936

Experimental

AL7182

Experimental

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

Experimental

4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole

Experimental

4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

PAS219

Experimental

(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester

Experimental

FR239087

Experimental

Phenacetin

Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn

1,3,5-trichlorobenzene

Experimental

4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

(P-Iodophenylacetylamino)Methylphosphinic Acid

Experimental

1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea

Experimental

N-(Chlorophenyl)-N'-hydroxyguanidine

Experimental

(R)-4-Nitrostyrene oxide

Experimental

SC45647

Experimental

Cannabinor

Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational

Indisulam

Investigational

N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide

Experimental

N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE

Experimental

1-[4-(hydroxymethyl)phenyl]guanidine

Experimental

N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE

Experimental

Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester

Experimental

(1R,2R,3R,4S,5R)-4-(Benzylamino)-5-(methylthio)cyclopentane-1,2,3-triol

Experimental
Displaying drugs 14326 - 14350 of 14623 in total